Eric Devroe serves as Executive at Acrivon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Eric Devroe has executed 10 insider transactions totaling $17.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 13, 2026 involved purchasing 10,000 shares valued at $17.2K.
Eric Devroe currently holds 75,308 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Devroe has been a net buyer of ACRV stock. They have purchased $17.2K and sold $0 worth of shares.
Eric Devroe's most recent insider trade was on Jan 13, 2026, when they purchased 10,000 shares at $1.72 per share.
Get notified when new Form 4 filings are submitted
| $2.24 |
| Discretionary |
| Aug 14, 2025 | ACRV | $852 | Payment | 613 | $1.39 | Discretionary |
| Aug 14, 2024 | ACRV | $4.3K | Payment | 613 | $7.02 | Discretionary |
| May 17, 2024 | ACRV | $10.4K | Option Exercise | 10,000 | $1.04 | Discretionary |
| May 14, 2024 | ACRV | $5.1K | Payment | 613 | $8.36 | Discretionary |
| Feb 14, 2024 | ACRV | $2.5K | Payment | 723 | $3.40 | Discretionary |
| Nov 14, 2023 | ACRV | $12.4K | Payment | 2,450 | $5.08 | Discretionary |
| Jun 5, 2023 | ACRV | $9.6K | Option Exercise | 9,225 | $1.04 | Discretionary |
| Nov 14, 2022 | ACRV | $0 | Award | 33,383 | $N/A | Discretionary |